Home - Products - Others - Other Targets - (Phenylac-Tyr1,D-Arg2,Phe(4-Cl)6,Homoarg9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Homoarg29)-GRF (1-29) amide (human)

(Phenylac-Tyr1,D-Arg2,Phe(4-Cl)6,Homoarg9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Homoarg29)-GRF (1-29) amide (human)

CAS No. 221377-79-3

(Phenylac-Tyr1,D-Arg2,Phe(4-Cl)6,Homoarg9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Homoarg29)-GRF (1-29) amide (human)( ——— )

Catalog No. M40234 CAS No. 221377-79-3

JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. JV-1-36 inhibits the production of reactive oxygen species in A549 lung cancer cells. JV-1-36 can be used to study the effect of GHRH antagonists in vitro .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 643 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Phenylac-Tyr1,D-Arg2,Phe(4-Cl)6,Homoarg9,Tyr(Me)10,Abu15,Nle27,D-Arg28,Homoarg29)-GRF (1-29) amide (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. JV-1-36 inhibits the production of reactive oxygen species in A549 lung cancer cells. JV-1-36 can be used to study the effect of GHRH antagonists in vitro .
  • Description
    JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. JV-1-36 inhibits the production of reactive oxygen species in A549 lung cancer cells. JV-1-36 can be used to study the effect of GHRH antagonists in vitro .
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IC50: growth hormone-releasing hormone (GHRH).
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    221377-79-3
  • Formula Weight
    3785.88
  • Molecular Formula
    C172H284ClN53O41
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kubra KT, et al. Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells. Endocrines. 2022 Dec;3(4):813-820.?
molnova catalog
related products
  • Casegravol

    Casegravol shows antiproliferative activity against human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells.

  • PACAP (6-38), human,...

    PACAP (6-38), human, ovine, rat is a potent antagonist of PACAP 38. PACAP (6-38) is much more potent and selective than PACAP (6-27) in the inhibition of PACAP-27-stimulated pituitary adenylate cyclase.

  • AUTAC1

    AUTAC1 is a MetAP2-targeted autophagy-mediated degrader (AUTAC) with potential anticancer activity that degrades MetAP2 and FKBP12 proteins and can be used to synthesize PROTAC.